1
TÍTULO: Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial
AUTORES: Rugo, HS; Im, SA; Cardoso, F; Cortes, J; Curigliano, G; Musolino, A; Pegram, MD; Bachelot, T; Wright, GS; Saura, C; Escrivá de Romaní, S; De Laurentiis, M; Schwartz, GN; Pluard, TJ; Ricci, F; Gwin, WR; 3rd; Levy, C; Brown Glaberman, U; Ferrero, JM; de Boer, M; Kim, SB; Petráková, K; Yardley, DA; Freedman, O; Jakobsen, EH; Gal Yam, EN; Yerushalmi, R; Fasching, PA; Kaufman, PA; Ashley, EJ; Perez Olle, R; Hong, S; Rosales, MK; Gradishar, WJ; Study Group SOPHIA; ...Mais
PUBLICAÇÃO: 2023, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 41, NÚMERO: 2
INDEXADO EM: Scopus WOS